Clinical Trials Browser

Phase 2 × Completed × Raloxifene Hydrochloride × Clear all

NCT00710970 2022-01-24

Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment

Phase 2 Completed

28 enrolled 8 charts

Urinary Bladder Neoplasms

NCT00019500 2013-06-20

Raloxifene in Preventing Breast Cancer in Premenopausal Women

Phase 2 Completed

Breast Neoplasms

NCT00004915 2012-06-06

Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer

Phase 2 Completed

Endometrial Neoplasms